These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19754353)

  • 1. Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications.
    Lippi G; Targher G; Franchini M; Plebani M
    Clin Chem Lab Med; 2009; 47(10):1183-94. PubMed ID: 19754353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac troponin I and troponin T: recent players in the field of myocardial markers.
    Chapelle JP
    Clin Chem Lab Med; 1999 Jan; 37(1):11-20. PubMed ID: 10094373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troponin T or troponin I or CK-MB (or none?).
    Collinson PO
    Eur Heart J; 1998 Nov; 19 Suppl N():N16-24. PubMed ID: 9857934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoforms of troponin in normal and diseased myocardium.
    Adamcová M; Pelouch V
    Physiol Res; 1999; 48(4):235-47. PubMed ID: 10638675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Troponin, a new myocardial infarction marker].
    Chapelle JP
    Rev Med Liege; 1998 Oct; 53(10):619-24. PubMed ID: 9857757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac troponin I and troponin T: are enzymes still relevant as cardiac markers?
    Mair J
    Clin Chim Acta; 1997 Jan; 257(1):99-115. PubMed ID: 9028628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple molecular forms of circulating cardiac troponin: analytical and clinical significance.
    Gaze DC; Collinson PO
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):349-55. PubMed ID: 18583618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality specifications for biochemical markers of myocardial injury.
    Zaninotto M; Mion M; Altinier S; Forni M; Plebani M
    Clin Chim Acta; 2004 Aug; 346(1):65-72. PubMed ID: 15234637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions at the NH2-terminal interface of cardiac troponin I modulate myofilament activation.
    Rarick HM; Tang HP; Guo XD; Martin AF; Solaro RJ
    J Mol Cell Cardiol; 1999 Feb; 31(2):363-75. PubMed ID: 10093049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal region of troponin T is essential for the maximal activation of rat cardiac myofilaments.
    Chandra M; Montgomery DE; Kim JJ; Solaro RJ
    J Mol Cell Cardiol; 1999 Apr; 31(4):867-80. PubMed ID: 10329214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutual rescues between two dominant negative mutations in cardiac troponin I and cardiac troponin T.
    Wei B; Gao J; Huang XP; Jin JP
    J Biol Chem; 2010 Sep; 285(36):27806-16. PubMed ID: 20551314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical and assay issues for use of cardiac troponin testing for risk stratification in primary care.
    Wu AHB; Christenson RH
    Clin Biochem; 2013 Aug; 46(12):969-978. PubMed ID: 23623945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant monocysteine mutant (Ser to Cys-155) of fast skeletal troponin T: identification by cross-linking of a domain involved in a physiologically relevant interaction with troponins C and I.
    Jha PK; Sarkar S
    Biochemistry; 1998 Sep; 37(35):12253-60. PubMed ID: 9724539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of cardiac troponins I and T in renal disease.
    Willging S; Keller F; Steinbach G
    Clin Chem Lab Med; 1998 Feb; 36(2):87-92. PubMed ID: 9594044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction.
    Rittoo D; Jones A; Lecky B; Neithercut D
    J Am Coll Cardiol; 2014 Jun; 63(22):2411-20. PubMed ID: 24747102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Role and Methods of Detection of Cardiac Troponins: An Opinion from Historical and Current Points of View.
    Michailovich Chaulin A
    Curr Cardiol Rev; 2023; 19(1):e100622205865. PubMed ID: 35702796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Interpretation of Elevated Concentrations of Cardiac Troponin T, but Not Troponin I, in Nursing Home Residents.
    Cardinaels EP; Daamen MA; Bekers O; ten Kate J; Niens M; van Suijlen JD; van Dieijen-Visser MP; Brunner-La Rocca HP; Schols JM; Mingels AM
    J Am Med Dir Assoc; 2015 Oct; 16(10):884-91. PubMed ID: 26255708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Cardiac Troponin T in Patients With Skeletal Myopathies.
    Schmid J; Liesinger L; Birner-Gruenberger R; Stojakovic T; Scharnagl H; Dieplinger B; Asslaber M; Radl R; Beer M; Polacin M; Mair J; Szolar D; Berghold A; Quasthoff S; Binder JS; Rainer PP
    J Am Coll Cardiol; 2018 Apr; 71(14):1540-1549. PubMed ID: 29622161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle.
    Ricchiuti V; Apple FS
    Clin Chem; 1999 Dec; 45(12):2129-35. PubMed ID: 10585344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in myocardial damage detection: new biochemical markers for clinicians.
    Mair J
    Crit Rev Clin Lab Sci; 1997; 34(1):1-66. PubMed ID: 9055056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.